STOCK TITAN
  1. Home
  2. SEC Filings
  3. CME
  4. [8-K] CME GROUP INC. Reports Material Event

CME Group Q3 2026 revenue hits record $1.74B

Trading activity reached a third-quarter record of 29.4 million contracts, while market data revenue reached $243.1 million, up 20%.

Filing Impact
(High)
Filing Sentiment

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment worksHow the balance works

Form Type
8-K

Rhea-AI Filing Summary

CME Group Inc. reported Q3 2026 revenue of $1,737.3 million, versus $1,537.6 million in Q3 2025. Operating income was $1,141.4 million, compared with $972.6 million, and net income was $1,036.9 million, versus $908.0 million. Diluted earnings per share were $2.89, compared with $2.49. On an adjusted, non-GAAP basis, operating income was $1,205.5 million, net income was $1,083.9 million and diluted earnings per share were $3.02.

Average daily volume reached a Q3 record of 29.4 million contracts, including 9 million non-U.S. contracts. Clearing and transaction fee revenue was $1,378.1 million, and the average rate per contract was $0.679. Market data revenue was a record $243.1 million, an increase of 20%. CME Group returned nearly $1 billion to shareholders during the quarter, including $465 million in regular quarterly dividends and $524 million in share repurchases.

As of September 30, 2026, CME Group reported $2.4 billion in cash and $3.4 billion of debt.

2 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

How the balance worksHow Sentiment works

0 major · 0 points

How the balance works

Positive

  • Moderate pointRecord Q3 revenue reached $1,737.3 million.
  • Moderate pointQ3 net income was $1,036.9 million, versus $908.0 million in 2025.

Negative

  • None.

Filing Explained

CME Group’s Q3 statements say all 4,584,000 preferred shares converted to Class A common stock on March 5, 2026; their weighted-average effect is included in diluted shares from Q1, recording the completed shift into common ownership.

Item 2.02 Results of Operations and Financial Condition Financial
Disclosure of earnings results, typically an earnings press release or preliminary financials.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Revenue $1,737.3 million Q3 2026; $1,537.6 million in Q3 2025
Operating income $1,141.4 million Q3 2026; $972.6 million in Q3 2025
Net income $1,036.9 million Q3 2026; $908.0 million in Q3 2025
Diluted earnings per share $2.89 Q3 2026; $2.49 in Q3 2025
Adjusted net income $1,083.9 million Q3 2026; $978.4 million in Q3 2025; non-GAAP measure
Adjusted diluted earnings per share $3.02 Q3 2026; $2.68 in Q3 2025; non-GAAP measure
Average daily volume 29.4 million contracts Q3 2026; third-quarter record
Market data revenue $243.1 million Q3 2026; record revenue, an increase of 20%
non-GAAP financial
"non-GAAP revenues, expenses, operating income, net income and earnings per share"
Non-GAAP refers to financial measures that companies use to show their earnings or performance without including certain expenses or income that are often added back to give a different picture. It matters because it can make a company's results look better or more favorable, but it may also hide important costs, so investors need to look at both GAAP (official rules) and non-GAAP numbers to get a full understanding.
Adjusted Earnings per Share financial
"Adjusted Earnings per Share Attributable to Common Shareholders of CME Group"
Adjusted Earnings Per Share shows how much profit a company makes for each share of stock, but it removes unusual or one-time items like big expenses or gains. This helps investors see the company's true ongoing performance, making it easier to compare how well different companies are doing over time.
Average Daily Volume (ADV) financial
"Quarterly Average Daily Volume (ADV)"
Average daily volume (ADV) is the typical number of shares or contracts traded in a security each trading day, calculated by averaging activity over a set recent period. It tells investors how easily a position can be bought or sold—like measuring foot traffic in a market stall: higher ADV means more buyers and sellers and usually smaller price swings when trades occur, while low ADV can lead to bigger price moves and trading difficulty.
Average Rate Per Contract (RPC) financial
"Quarterly Average Rate Per Contract (RPC)"
Revenue $1,737.3 million Q3 2025: $1,537.6 million
Operating income $1,141.4 million Q3 2025: $972.6 million
Net income $1,036.9 million Q3 2025: $908.0 million
Diluted earnings per share $2.89 Q3 2025: $2.49
Adjusted operating income $1,205.5 million Q3 2025: $1,051.0 million
Adjusted net income $1,083.9 million Q3 2025: $978.4 million
Adjusted diluted earnings per share $3.02 Q3 2025: $2.68

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What was CME's Q3 2026 revenue?
CME Group reported Q3 2026 revenue of $1,737.3 million, compared with $1,537.6 million in Q3 2025.

What was CME's net income in Q3 2026?
CME Group's Q3 2026 net income was $1,036.9 million, compared with $908.0 million in Q3 2025. Adjusted net income was $1,083.9 million.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Available on EDGAR Accepted by SEC EDGAR
false000115637500011563752026-10-212026-10-21

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549 
_________________________________________________________
FORM 8-K
 _________________________________________________________
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported) October 21, 2026
 
 _________________________________________________________
CME GROUP INC.
(Exact Name of Registrant as Specified in its Charter) 
_________________________________________________________ 
Delaware001-3155336-4459170
(State or Other Jurisdiction
of Incorporation)		(Commission
File No.)		(IRS Employer
Identification No.)
20 South Wacker DriveChicagoIllinois60606
(Address of Principal Executive Offices)(Zip Code)
Registrant’s telephone number, including area code: (312) 930-1000
N/A
(Former Name or Former Address, if Changed Since Last Report) 
______________________________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading symbolName of each exchange on which registered
Class A Common StockCMENasdaq
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405) of this chapter or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐


Item 2.02.Results of Operations and Financial Condition.
The information set forth under “Item 2.02. Results Of Operations and Financial Condition,” including the Exhibit attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.
Attached and incorporated herein by reference as Exhibit 99.1 is a copy of a press release of CME Group Inc. dated October 21, 2026, reporting CME Group Inc.’s financial results for the quarter ended September 30, 2026.
To supplement CME Group’s financial statements on a GAAP basis, the attached press release includes financial measures that are not in accordance with GAAP, consisting of non-GAAP revenues, expenses, operating income, net income and earnings per share. Management believes that the presentation of non-GAAP revenues, expenses, operating income, net income and earnings per share provide important supplemental information to management and investors about financial and business trends relating to CME Group Inc.’s financial condition and results of operations. Management believes that the use of these non-GAAP financial measures provide a better measure of comparability with the Company’s prior financial reports. Management acknowledges that non-GAAP adjustments may include recurring items. These non-GAAP measures should be considered as a supplement to, and not as a substitute for, or superior to, the corresponding measures calculated in accordance with GAAP. Pursuant to the requirements of Regulation G, CME Group Inc. has included a reconciliation of the non-GAAP financial measures to the most directly comparable GAAP financial measures in the press release.
 
Item 9.01Financial Statements and Exhibits.
Exhibit
Number		  Description
99.1   
Press Release, dated October 21, 2026.
104 The cover page from CME Group Inc.'s Current Report on Form 8-K, formatted in Inline XBRL.



SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
CME Group Inc.
Registrant
Date: October 21, 2026By:/s/ Lynne Fitzpatrick
Name:

Title:		Lynne Fitzpatrick

Senior Managing Director, President and Chief Financial Officer

Principal Financial Offer and
Duly Authorized Officer
































                                             Exhibit 99.1
cmeglogoa.jpg
Media contactInvestor contact
Laurie Bischel, 312.292.1937Adam Minick, 312.340.8365
news@cmegroup.cominvestors@cmegroup.com
cmegroup.mediaroom.comCME-G
FOR IMMEDIATE RELEASE
CME Group Inc. Reports Highest Q3 Revenue on Record for Q3 2026
•Double-digit revenue and net income growth
CHICAGO, October 21, 2026 - CME Group Inc. (NASDAQ: CME) today reported financial results for the third quarter of 2026.
The company reported revenue of $1.7 billion and operating income of $1.1 billion for the third quarter of 2026. Net income was $1.0 billion and diluted earnings per common share were $2.89. On an adjusted basis, operating income was $1.2 billion, net income was $1.1 billion and diluted earnings per common share were $3.02. Financial results presented on an adjusted basis for the third quarter of 2026 and 2025 exclude certain items, which are detailed in the reconciliation of non-GAAP results.1    
"As uncertainty intensified in Q3, clients turned to CME Group in record numbers to manage risk and capitalize on opportunities," said CME Group Chairman and Chief Executive Officer Terry Duffy. "Our average daily volume reached 29.4 million contracts, the highest Q3 ADV on record. With double-digit volume growth across all six asset classes, Q3 was our second highest quarter ever for revenue and adjusted net income. We launched several innovative new products and generated a new high of $100 billion in average daily capital efficiencies. We also made strong progress in our cloud migration, making CME Group the only exchange to offer clients the choice of both co-location and cloud-managed services to expand access to our markets for years to come."
Q3 2026 average daily volume (ADV) climbed to a third-quarter record of 29.4 million contracts, and non-U.S. ADV reached a third-quarter high of 9 million contracts.
Clearing and transaction fees revenue for third-quarter 2026 totaled $1.4 billion. The total average rate per contract was $0.679. Market data revenue totaled a record $243 million for third-quarter 2026, an increase of 20%.


1. A reconciliation of the non-GAAP financial results mentioned to the respective GAAP figures can be found within the Reconciliation of Adjusted Operating Income and Adjusted Net Income and Adjusted Earnings per Common Share charts at the end of the financial statements.
- more -





Page 2
As of September 30, 2026, the company had $2.4 billion in cash (including $225 million deposited with Fixed Income Clearing Corporation, which is included in other current assets) and $3.4 billion of debt. The company returned nearly $1 billion to shareholders during the quarter, with $465 million in regular quarterly dividends and $524 million in share repurchases.
CME Group will hold a Q&A conference call to discuss third-quarter 2026 results at 8:30 a.m. Eastern Time today. A live audio webcast of the Q&A call will be available on the Investor Relations section of CME Group's website at investor.cmegroup.com under Events & Presentations. An archived recording will be available for up to two months after the call.
As the world's leading derivatives marketplace, CME Group (www.cmegroup.com) enables clients to trade futures, options, cash and OTC markets, optimize portfolios, and analyze data – empowering market participants worldwide to efficiently manage risk and capture opportunities. CME Group exchanges offer the widest range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange, cryptocurrencies, energy, agricultural products and metals. The company offers futures and options on futures trading through the CME Globex platform, fixed income trading via BrokerTec and foreign exchange trading on the EBS platform. In addition, it operates one of the world's leading central counterparty clearing providers, CME Clearing.

CME Group, the Globe logo, CME, Chicago Mercantile Exchange, Globex, and E-mini are trademarks of Chicago Mercantile Exchange Inc. CBOT and Chicago Board of Trade are trademarks of Board of Trade of the City of Chicago, Inc. NYMEX, New York Mercantile Exchange and ClearPort are trademarks of New York Mercantile Exchange, Inc. COMEX is a trademark of Commodity Exchange, Inc. BrokerTec is a trademark of BrokerTec Americas LLC and EBS is a trademark of EBS Group LTD. The S&P 500 Index is a product of S&P Dow Jones Indices LLC (“S&P DJI”). “S&P®”, “S&P 500®”, “SPY®”, “SPX®”, US 500 and The 500 are trademarks of Standard & Poor’s Financial Services LLC; Dow Jones®, DJIA® and Dow Jones Industrial Average are service and/or trademarks of Dow Jones Trademark Holdings LLC. These trademarks have been licensed for use by Chicago Mercantile Exchange Inc. Futures contracts based on the S&P 500 Index are not sponsored, endorsed, marketed, or promoted by S&P DJI, and S&P DJI makes no representation regarding the advisability of investing in such products. All other trademarks are the property of their respective owners.



















- more -





Page 3

Statements in this press release that are not historical facts are forward-looking statements. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or implied in any forward-looking statements. We want to caution you not to place undue reliance on any forward-looking statements. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise. Among the factors that might affect our performance are increasing competition by foreign and domestic entities, including increased competition from new entrants into our markets and consolidation of existing entities; our ability to keep pace with rapid technological developments, including our ability to complete the development, implementation and maintenance of the enhanced functionality required by our customers while maintaining reliability and ensuring that such technology is not vulnerable to security risks; our ability to continue introducing innovative and competitive new products and services on a timely, cost-effective basis, including through our electronic trading capabilities, and derive revenues that are commensurate with our efforts and expectations, and our ability to maintain the competitiveness of our existing products and services; our ability to adjust our fixed costs and expenses if our revenues decline; our ability to manage variable costs associated with CME Group’s transition to the Google Cloud, and minimize duplicative costs of maintaining both on-premise and Google Cloud environments during the transition; the resilience of our electronic platforms and the soundness of our business continuity and disaster recovery plans, including in the event of cyberattacks and cyberterrorism or as impacted by a failure of or disruption at one of our suppliers; our ability to maintain existing customers at substantially similar trading levels, develop strategic relationships and attract new customers; our ability to expand and globally offer our products and services; changes in regulations, including the impact of any changes in laws or government policies with respect to our products or services or our industry, such as any changes to regulations and policies that require increased financial and operational resources from us or our customers, as well as the impact of tariffs and tax policy changes, restrictions on our ability to offer CME Group products and services in specific geographies or to specific customers or limitations or changes in underlying/physical product flows across geographies; the costs associated with protecting our intellectual property rights and our ability to operate our business without violating the intellectual property rights of others; decreases in revenue from our market data as a result of decreased demand or changes to regulations in various jurisdictions; changes in our rate per contract due to shifts in the mix of the products traded, the trading venue and the mix of customers (whether the customer receives member or non-member fees or participates in one of our various incentive programs) and the impact of our tiered pricing structure; the ability of our credit and liquidity risk management practices to adequately protect us from the credit risks of clearing firms and other counterparties, and to satisfy the margin and liquidity requirements associated with the BrokerTec matched principal business; the ability of our compliance and risk management programs to effectively monitor and manage our risks, including our ability to prevent errors and misconduct and protect our infrastructure against security breaches and misappropriation of our intellectual property assets; our dependence on third-party providers and exposure to risk from third parties, including risks related to the performance, reliability and security of technology used by, or facilities provided by, our third-party providers and third-party providers that our clients and third-parties rely on; our reliance on third-party distribution partners, including independent software vendors, futures commission merchants, introducing brokers, broker-dealers, regulatory reporting and data distributors and platform operators, and other partners, for facilitating trading and for market data information, and potential impacts from changes in their business models and priorities; volatility in commodity, equity and fixed income prices, and price volatility of financial benchmarks and instruments such as interest rates, equity indices, fixed income instruments and foreign exchange rates; economic, social, political and market conditions, including new and existing geopolitical tensions or conflicts, the volatility of the capital and credit markets and the impact of economic conditions on the trading activity of our current and potential customers; our ability to accommodate increases in contract volume and market data and order transaction traffic across the entire trade cycle and the ability to implement enhancements meeting our regulatory obligations and customer needs without failure or degradation of the performance of our trading and clearing systems; our ability to execute our growth strategy and maintain our growth effectively; our ability to manage the risks, control the costs and achieve the synergies associated with our strategy for acquisitions, investments, alliances, strategic partnerships and joint ventures; variances in earnings on cash accounts and collateral that our clearing house holds; impact of CME Group pricing/fee level and structure and incentive changes; impact of aggregation services and internalization on trade flow and volumes; any negative financial impacts from changes to the terms of intellectual property and index rights; our ability to continue to generate funds and/or manage our indebtedness to allow us to continue to invest in our business; industry, channel partner and customer consolidation and/or concentration; decreases in trading and clearing activity; the imposition of a transaction tax or user fee on





futures and options transactions and/or repeal of the 60/40 tax treatment of such transactions; increases in effective tax rates, borrowing costs, or changes in tax policy; our ability to maintain our brand and reputation; and the unfavorable resolution of material legal proceedings. For a detailed discussion and additional information concerning these and other factors that might affect our performance, see our other recent periodic filings, including our Annual Report on Form 10-K for the year ended December 31, 2025, as filed with the Securities and Exchange Commission ("SEC") on February 26, 2026, under the caption "Risk Factors".
# # #






CME Group Inc. and Subsidiaries
Consolidated Balance Sheets
(in millions)
 
September 30, 2026December 31, 2025
ASSETS
Current Assets:
Cash and cash equivalents$2,198.5 $4,416.9 
Marketable securities131.0 125.0 
Accounts receivable, net of allowance788.1 639.2 
Other current assets (includes $3.5 and $6.5 in restricted cash)840.9 522.1 
Performance bonds and guaranty fund contributions155,179.7 159,656.1 
Total current assets159,138.2 165,359.3 
Property, net of accumulated depreciation and amortization338.7 362.7 
Intangible assets—trading products17,175.3 17,175.3 
Intangible assets—other, net2,440.1 2,610.7 
Goodwill10,505.9 10,514.7 
Other assets 2,494.3 2,401.5 
Total Assets$192,092.5 $198,424.2 
LIABILITIES AND EQUITY
Current Liabilities:
Accounts payable$67.7 $71.8 
Other current liabilities865.5 568.8 
Performance bonds and guaranty fund contributions155,179.7 159,656.1 
Total current liabilities156,112.9 160,296.7 
Long-term debt3,425.1 3,422.3 
Deferred income tax liabilities, net5,208.6 5,242.2 
Other liabilities785.6 734.8 
Total Liabilities165,532.2 169,696.0 
Total CME Group Shareholders’ Equity26,560.3 28,728.2 
Total Liabilities and Equity$192,092.5 $198,424.2 
















CME Group Inc. and Subsidiaries
Consolidated Statements of Income
(dollars in millions, except per share amounts; shares in thousands)
Quarter Ended
September 30,		Nine Months Ended
September 30,
2026202520262025
Revenues
Clearing and transaction fees$1,378.1 $1,227.9 $4,273.2 $3,953.2 
Market data and information services243.1 202.5 705.3 595.1 
Other116.1 107.2 345.1 323.6 
Total Revenues1,737.3 1,537.6 5,323.6 4,871.9 
Expenses
Compensation and benefits234.3 237.6 690.8 665.9 
Technology80.9 71.4 240.8 208.0 
Professional fees and outside services31.1 36.7 88.4 102.6 
Amortization of purchased intangibles56.0 56.2 168.1 167.5 
Depreciation and amortization27.4 26.4 82.8 81.0 
Licensing and other fee agreements104.2 81.6 320.1 274.4 
Other62.0 55.1 174.4 162.6 
Total Expenses595.9 565.0 1,765.4 1,662.0 
Operating Income1,141.4 972.6 3,558.2 3,209.9 
Non-Operating Income (Expense)
Investment income1,418.1 1,548.7 4,237.1 3,959.8 
Interest and other borrowing costs(43.5)(44.0)(130.7)(129.7)
Equity in net earnings of unconsolidated subsidiaries102.8 96.3 302.9 283.5 
Other non-operating income (expense)(1,264.0)(1,396.6)(3,774.1)(3,571.4)
Total Non-Operating Income (Expense)213.4 204.4 635.2 542.2 
Income before Income Taxes1,354.8 1,177.0 4,193.4 3,752.1 
Income tax provision 317.9 269.0 960.4 862.8 
Net Income$1,036.9 $908.0 $3,233.0 $2,889.3 
Net Income Attributable to Common Shareholders of CME Group - Basic(1)
$1,036.9 $896.6 $3,234.2 $2,853.0 
Net Income Attributable to Common Shareholders of CME Group - Diluted(1)
$1,036.9 $896.6 $3,233.0 $2,853.0 
Earnings per Share Attributable to Common Shareholders of CME Group:
Basic$2.90 $2.49 $9.00 $7.93 
Diluted2.89 2.49 8.96 7.92 
Weighted Average Number of Common Shares:
Basic358,019 359,686 359,336 359,653 
Diluted(2)
358,641 360,422 361,018 360,330 
1. The difference between Net Income and Net Income Attributable to Common Shareholders of CME Group - Basic and Diluted is the result of the distribution of earnings allocated to preferred shares.
2. Preferred shares of 4,584,000 were all converted to Class A Common stock on March 5, 2026 with their weighted-average impact included in the Diluted shares starting in the first quarter of 2026.






CME Group Inc. and Subsidiaries
Reconciliation of Adjusted Operating Income
(dollars in millions)
Quarter Ended
September 30,		Nine Months Ended
September 30,
2026202520262025
Total Revenues$1,737.3 $1,537.6 $5,323.6 $4,871.9 
Adjusted Total Revenues $1,737.3 $1,537.6 $5,323.6 $4,871.9 
Total Expenses$595.9 $565.0 $1,765.4 $1,662.0 
Restructuring and severance(5.4)(6.5)(15.4)(9.0)
Deferred compensation(1)
0.1 (6.1)(11.5)(11.6)
Amortization of purchased intangibles(56.0)(56.2)(168.1)(167.5)
Strategic transaction-related (costs) credits(0.7)(1.2)(2.3)(4.0)
Real estate-related (costs) credits(0.7)(0.7)(0.7)7.4 
Foreign exchange transaction gains (losses)(1.4)0.8 (0.8)(5.1)
Unrealized and realized gains (losses) on assets — — — (0.4)
Litigation matters or settlements— (8.5)(1.9)(19.4)
Adjusted Total Expenses $531.8 $486.6 $1,564.7 $1,452.4 
Operating Income $1,141.4 $972.6 $3,558.2 $3,209.9 
Adjusted Operating Income$1,205.5 $1,051.0 $3,758.9 $3,419.5 
1. Includes $0.1 million and $11.5 million for changes in our non-qualified deferred compensation liability in the third quarter and first nine months of 2026. This impact does not affect net income and adjusted net income, because the compensation and benefits change has an equal and offsetting change in investment income.





CME Group Inc. and Subsidiaries
Reconciliation of Adjusted Net Income and Adjusted Earnings per Common Share
(dollars in millions, except per share amounts; shares in thousands)
Quarter Ended
September 30,		Nine Months Ended
September 30,
2026202520262025
Net Income $1,036.9 $908.0 $3,233.0 $2,889.3 
Restructuring and severance5.4 6.5 15.4 9.0 
Amortization of purchased intangibles(1)
60.0 69.6 180.1 207.2 
Strategic transaction-related costs (credits)(2)
— 3.7 0.4 6.5 
Real estate-related costs (credits)0.7 0.7 0.7 (7.4)
Foreign exchange transaction (gains) losses1.4 (0.8)0.8 5.1 
Unrealized and realized (gains) losses on investments0.1 (0.4)19.1 6.1 
Unrealized and realized (gains) losses on assets— — — 0.4 
Litigation matters or settlements— 8.5 1.9 19.4 
Income tax effect related to above(16.3)(18.2)(52.6)(49.8)
Other income tax items(4.3)0.8 (13.1)(8.1)
Adjusted Net Income $1,083.9 $978.4 $3,385.7 $3,077.7 
Adjusted Net Income Attributable to Common Shareholders of CME Group - Basic(3)
$1,083.9 $966.1 $3,386.4 $3,039.0 
Adjusted Net Income Attributable to Common Shareholders of CME Group - Diluted(3)
$1,083.9 $966.1 $3,385.7 $3,039.0 
Earnings per Share Attributable to Common Shareholders of CME Group:
     Basic$2.90 $2.49 $9.00 $7.93 
     Diluted2.89 2.49 8.96 7.92 
Adjusted Earnings per Share Attributable to Common Shareholders of CME Group:
     Basic$3.03 $2.69 $9.42 $8.45 
     Diluted3.02 2.68 9.38 8.43 
Weighted Average Number of Common Shares:
     Basic358,019 359,686 359,336 359,653 
     Diluted(4)
358,641 360,422 361,018 360,330 
1. Includes $2.6 million and $7.8 million of amortization of purchased intangibles at S&P Dow Jones Indices LLC and $1.4 million and $4.2 million of amortization of purchased intangibles at FanDuel Prediction Markets Holdings LLC in the third quarter and first nine months of 2026. This is reported in Equity in net earnings of unconsolidated subsidiaries on the Consolidated Statements of Income.
2. The values shown above may differ from what is shown in the Reconciliation of Adjusted Operating Income as
that schedule does not include adjustment items or portions of items included in non-operating results.
3. The difference between Adjusted Net Income and Adjusted Net Income Attributable to Common Shareholders of CME Group - Basic and Diluted is the result of the distribution of earnings allocated to preferred shares.
4. Preferred shares of 4,584,000 were all converted to Class A Common stock on March 5, 2026 with their weighted-average impact included in the Diluted shares starting in the first quarter of 2026.






CME Group Inc. and Subsidiaries
Quarterly Operating Statistics
 
3Q 20254Q 20251Q 20262Q 20263Q 2026
Trading Days64 64 61 62 64 
Quarterly Average Daily Volume (ADV)(1)
CME Group ADV (in thousands)
 
Product Line3Q 20254Q 20251Q 20262Q 20263Q 2026
Interest rates13,378 13,010 18,674 14,532 15,121 
Equity indexes6,278 7,738 8,655 8,633 7,714 
Foreign exchange834 853 1,193 989 988 
Energy2,295 2,523 3,985 2,667 2,665 
Agricultural commodities1,712 1,787 2,042 2,080 2,022 
Metals825 1,441 1,682 941 935 
Total25,322 27,353 36,231 29,843 29,445 
Venue
CME Globex23,418 25,542 33,633 27,935 27,472 
Open outcry 989 816 1,241 830 872 
Privately negotiated915 995 1,357 1,078 1,100 
Total25,322 27,353 36,231 29,843 29,445 
Quarterly Average Rate Per Contract (RPC)(1)
CME Group RPC
 
Product Line3Q 20254Q 20251Q 20262Q 20263Q 2026
Interest rates$0.487 $0.486 $0.457 $0.480 $0.489 
Equity indexes0.652 0.611 0.597 0.605 0.605 
Foreign exchange0.841 0.847 0.780 0.813 0.852 
Energy1.214 1.245 1.084 1.131 1.146 
Agricultural commodities1.423 1.427 1.344 1.426 1.377 
Metals1.505 1.295 1.153 1.315 1.326 
Average RPC$0.702 $0.707 $0.652 $0.678 $0.679 
1. ADV and RPC includes futures and options on futures only.





Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

4 documents

Press Releases

Other Documents

Keep reading

More on CME

All CME news

Trending in the feed

SHMD
SCHMID Group Reaches Agreement on Significant Equipment Order to Support HDI Capacity Expansion in Malaysia Open the live feed